Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Platelet signaling at the nexus of innate immunity and rheumatoid arthritis. | Front Immunol | 2022 | 36505402 | PubTator, text mining | PubMed |
| The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies. | Int J Mol Sci | 2022 | 36499242 | PubTator, text mining | PubMed |
| Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis. | Cells | 2022 | 36496998 | PubTator, text mining | PubMed |
| Platelet in thrombo-inflammation: Unraveling new therapeutic targets. | Front Immunol | 2022 | 36451834 | PubTator, text mining | PubMed |
| Remodeling tumor microenvironment with natural products to overcome drug resistance. | Front Immunol | 2022 | 36439106 | PubTator, text mining | PubMed |
| Relationship between the Responsiveness of Amyloid β Protein to Platelet Activation by TRAP Stimulation and Brain Atrophy in Patients with Diabetes Mellitus. | Int J Mol Sci | 2022 | 36430576 | PubTator, text mining | PubMed |
| Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. | Int J Mol Sci | 2022 | 36430344 | PubTator, text mining | PubMed |
| Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment. | J Cardiovasc Dev Dis | 2022 | 36421932 | PubTator, text mining | PubMed |
| Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection. | Biochem Mosc Suppl B Biomed Chem | 2022 | 36407837 | PubTator, text mining | PubMed |
| Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions. | Indian J Clin Biochem | 2022 | 36407686 | PubTator, text mining | PubMed |
| The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease. | Cardiovasc Diabetol | 2022 | 36403025 | PubTator, text mining | PubMed |
| Activation of Human Platelets by Staphylococcus aureus Secreted Protease Staphopain A. | Pathogens | 2022 | 36364988 | PubTator, text mining | PubMed |
| Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? | Int J Mol Sci | 2022 | 36362186 | PubTator, text mining | PubMed |
| Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications. | Int J Mol Sci | 2022 | 36361561 | PubTator, text mining | PubMed |
| Tissue Factor, Thrombosis, and Chronic Kidney Disease. | Biomedicines | 2022 | 36359257 | PubTator, text mining | PubMed |
| Endogenous reparative pluripotent Muse cells with a unique immune privilege system: Hint at a new strategy for controlling acute and chronic inflammation. | Front Pharmacol | 2022 | 36339573 | PubTator, text mining | PubMed |
| Adjunctive platelet-rich plasma and hyaluronic acid injection after arthroscopic debridement in Kellgren-Lawrence grade 3 and 4 knee osteoarthritis. | World J Orthop | 2022 | 36312525 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Study Identifies Novel Rare Risk Variants for Habitual Coffee Consumption Involved in Olfactory Receptor and Hyperphagia. | Nutrients | 2022 | 36297015 | PubTator, text mining | PubMed |
| Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability. | Int J Mol Sci | 2022 | 36293367 | PubTator, text mining | PubMed |
| Reduction in SOCE and Associated Aggregation in Platelets from Mice with Platelet-Specific Deletion of Orai1. | Cells | 2022 | 36291093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=14